Cargando…
Antihypertensive medication classes and the risk of dementia over a decade of follow-up
INTRODUCTION: Use of angiotensin II (ATII)-stimulating antihypertensive medication (AHM), including angiotensin receptor blockers (ARBs) and dihydropyridine calcium channel blockers (CCBs), has been associated with lower dementia risk. Previous studies had relatively short follow-up periods. The aim...
Autores principales: | Schroevers, Jakob L., Eggink, Esmé, Hoevenaar-Blom, Marieke P., Van Dalen, Jan Willem, Van Middelaar, Tessa, Van Gool, Willem A., Richard, Edo, Moll Van Charante, Eric P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9799049/ https://www.ncbi.nlm.nih.gov/pubmed/36394298 http://dx.doi.org/10.1097/HJH.0000000000003324 |
Ejemplares similares
-
Modifiable dementia risk score to study heterogeneity in treatment effect of a dementia prevention trial: a post hoc analysis in the preDIVA trial using the LIBRA index
por: van Middelaar, Tessa, et al.
Publicado: (2018) -
Low Values for Blood Pressure, BMI, and Non-HDL Cholesterol and the Risk of Late-Life Dementia
por: den Brok, Melina G.H.E., et al.
Publicado: (2022) -
A Population Perspective on Prevention of Dementia
por: Eggink, Esmé, et al.
Publicado: (2019) -
Attitudes and views on healthy lifestyle interventions for the prevention of dementia and cardiovascular disease among older people with low socioeconomic status: a qualitative study in the Netherlands
por: Eggink, Esmé, et al.
Publicado: (2022) -
Association of Angiotensin II–Stimulating Antihypertensive Use and Dementia Risk: Post Hoc Analysis of the PreDIVA Trial
por: van Dalen, Jan Willem, et al.
Publicado: (2021)